Explore how precision targeting, advanced disease models, and theranostic pairs are transforming molecular radiotherapy for cancer treatment.
Discover how 68Ga/177Lu-PSMA I&T is transforming prostate cancer treatment through theranostics, combining precise diagnosis with targeted therapy.